The European Commission launched a proposal in July 2023 to deregulate a large number of plants manufactured using new genetic techniques.
Biotechnology
Dec 18, 2023
0
12
In a quiet business park far from Seattle's booming South Lake Union, players in the Northwest's "other" tech sector are coping with growing pains of their own.
Business
Jan 31, 2019
0
6
New York-based pharmaceutical giant Bristol-Myers Squibb on Thursday announced it would buy US biotech firm Celgene in a $74 billion cash-and-stock deal, creating a rival to the world's largest drug makers.
Business
Jan 3, 2019
0
10
As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating ...
Other
Dec 5, 2018
0
6
Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.
Business
May 28, 2015
0
18
Female professors are almost 50 percent less likely than their male counterparts to be invited to join corporate scientific advisory boards (SABs) and start new companies mainly because of gender stereotyping, says University ...
Social Sciences
Mar 12, 2013
0
0
Environmentalists are warning that Mexico, the cradle of corn, risks damaging its staple if the government gives US firms the green light to plant genetically-modified maize in huge swaths of land.
Biotechnology
Nov 20, 2012
2
0
The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no returns at all. ...
Biotechnology
Oct 4, 2012
0
0
The lure of greater profits elsewhere in the world may divert bio-pharmaceutical firms in developing countries from the creation and distribution of affordable drugs, vaccines and diagnostics for illnesses of local concern, ...
Biotechnology
Sep 9, 2010
0
0
The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries, ...
Biotechnology
May 10, 2010
0
0
